Usana Health Sciences (USNA) Cash from Operations (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Cash from Operations data on file, last reported at 9759000.0 in Q2 2026.

• Cash from Operations for Q2 2026 came in at 9759000.0, down 36.97% year-over-year; the trailing twelve-month figure through Apr 2026 was 16626000.0 (down 71.72% YoY), and the FY2026 annual result was 22349000.0, down 63.36% from the prior year.
• Cash from Operations rose to 9759000.0 in Q2 2026 per USNA's latest filing, from 3390000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 40463000.0 in Q4 2022 and troughed at 3390000.0 in Q1 2026.
• A 5-year average of 15354666.67 and a median of 13723000.0 in 2022 frame the typical range for Cash from Operations.
• The sharpest annual moves came in 2022 and 2026: Cash from Operations surged 362.91% in 2022, then slumped 158.6% in 2026.
• A 5-year view of Cash from Operations shows it stood at 40463000.0 in 2022, then plunged by 35.69% to 26023000.0 in 2023, then sank by 77.77% to 5785000.0 in 2024, then sank by 133.9% to 1961000.0 in 2025, then surged by 597.65% to 9759000.0 in 2026.
• Business Quant data shows USNA's Cash from Operations at 9759000.0 in Q2 2026, 3390000.0 in Q1 2026, and 1961000.0 in Q3 2025.